India's preferred Personal finance destination
Home Shares News Centre F&O Mutual Funds IPO Portfolio Commodity Loans Financial Planning Insurance About Us
Markets Companies Research Industries E-Mail Page
Wealth Tracker      Tax Corner NRI Centre Chat Masala Feedback

my Last 5 Scrips
Company BSE Price(Rs) % Chg
Adani Po 400.90 2.23
Icici Ba 277.10 2.77
Coal Ind 253.90 0.12
State Ba 261.90 2.46
Tata Mot 411.20 0.51
Clear All Clear Last
Equity
NSE Live
Nifty Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
BSE Live
BSE30 Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
IPO Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Discussion Forum
Research
Research Reports
News Watch
Sector Watch
Economy Watch
News-Dr Reddy`S Laboratories Limited
Dr Reddy`S Laboratories Limited
Sector:Pharmaceuticals Pharmaceuticals - Bulk Drugs and Formulations
BSE:500124NSE:DRREDDYBloomberg:DRRD@INReuters:REDY.BO
Market Lot: 1Face Value: 5ISIN Demat: INE089A01023
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

 
Corporate News
22-Aug-2017       Dr Reddy's to get up to USD 32.5 mn milestone payments for DFD-06 IRIS
28-Jul-2017       Dr. Reddy's Lab enters into global licensing pact with CHD Bioscience IRIS
21-Jul-2017       USFDA completes audit at Dr. Reddy's API Cuernavaca plant in Mexico IRIS
19-Jun-2017       Dr. Reddy's receives USFDA observations for Srikakulam facility IRIS
15-Jun-2017       Dr. Reddy's Lab recalls 3.25 lakh cartons of Zenatane capsules from US IRIS
14-Jun-2017       Dr Reddy's climbs after USFDA clearance for plant IRIS
14-Jun-2017       Dr. Reddy's Lab receives EIR from USFDA for Miryalaguda facility IRIS
26-May-2017       Dr. Reddy' rises on successfully completing USFDA audit for Srikakulum Plant IRIS
17-May-2017       Dr Reddy's gets approval for Doxorubicin HCl injections IRIS
16-May-2017       Dr Reddy's Labs launches generic Sofosbuvir & Velpatasvir tablets IRIS
12-May-2017       Dr Reddy's Lab quarterly net zooms 2.75 times IRIS
02-May-2017       Dr Reddy's Lab gets 11 USFDA observations for Bachupally unit IRIS
27-Apr-2017       Dr. Reddy's Lab launches Ezetimibe & Simvastatin tablets in US IRIS
05-Apr-2017       Dr Reddy's Lab gets 2 USFDA observations for Srikakulam facility IRIS
09-Mar-2017       Dr Reddy's Labs tanks as Duvvada facility receives 13 USFDA observations IRIS
09-Mar-2017       Dr Reddy's Labs tanks as Duvvada facility receives 13 USFDA observations IRIS
06-Mar-2017       Dr. Reddy's Lab concludes acquisition of 100% stake in Imperial Credit IRIS
22-Feb-2017       DRL gets 3 USFDA observations for Miryalaguda facility IRIS
05-Dec-2016       Dr Reddy's Lab launches of Nystatin, Triamcinolone Acetonide cream in US market IRIS
27-Oct-2016       Dr. Reddy's Lab announces new strategic deal with Gland Pharma IRIS

 

 


Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Wealth Tracker | Tax Corner | NRI Centre | Search in myiris | Advertise
All rights reserved. IRIS Business Services Limited
Disclaimer